Breaking Medical News and In Depth Medical Stories

 
Search News:
     
PROGRAMS
 
 
Report suggests extending follow-up with ranibizumab for diabetic macular edema
Report suggests extending follow-up with ranibizumab for diabetic macular edema

(February 28, 2013 - Insidermedicine)

From Baltimore – A new report published in JAMA Ophthalmology finds that increasing follow-up with ranibizumab in diabetic macular edema patients may improve their long-term visual outcomes. Researchers studied over 70 diabetic macular edema patients, randomizing participants to receive either ranibizumab, laser, or ranibizumab plus laser. Participants were followed up between 24-36 months, with the main outcome measure being improvement in best-corrected visual acuity and reduction in foveal thickness. Results showed that the more aggressive treatment in the ranibizumab group resulted in a reduction in mean foveal thickness and improvement in best-corrected visual activity. Differences achieved in the other two groups were not statistically significant.

 
OUR TEAM
More...  
EDITORIAL BOARD
More...